Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Pharmacy funding cuts

Stakes are too high for a wait-and-see approach

The UK government’s documents on funding cuts for community pharmacy are inconsistent and lack evidence.

Closed pharmacy

Source: Konstantinos Tsakalidis / Alamy Stock Photo

After ten months of anxious speculation, pharmacy contractors and their staff have received the first concrete details of how the UK government plans to deliver cuts to funding payable to community pharmacies in England. When David Mowat, parliamentary under secretary of state for community health and care, addressed Parliament on 20 October 2016, he told MPs that the current payment structure for community pharmacy is outdated and overly complex and so will be consolidated into one single activity fee. Establishment payments, which pharmacies are entitled to claim if they dispense more than 2,500 items a month, will be phased out by 2018.

Every pharmacy will need to survive on less money or close for business. In England, funding for community pharmacy will be reduced by 4% for 2016–2017 to £2.687bn, starting from 1 December 2016. The 4% cut will be taken in its entirety over four months of the year, so contractors will experience a 12% pay cut in that period. This will be followed by a further cut of 3.4% for 2017–2018, reducing the funding to £2.592bn.

Up to £75m of the £2.592bn budget for 2017–2018 will be allocated to a new quality payment scheme from April 2017. Pharmacies will have to meet four criteria before they will be considered for the payment, including provision of at least one specified advanced service and ongoing use of the electronic prescription service. A focus on quality must be applauded but the scheme needs to be easy for contractors to navigate if it is to achieve its aims. And whether the quality criteria chosen by the Department of Health (DH) really will reward excellence remains to be seen.

The new pharmacy integration fund (PhIF), aimed at supporting the development of clinical pharmacy practice in a range of primary care settings, has been reduced from an expected £300m by 2021 to £42m over the next two years. The sector has been told that part of the PhIF will be used to fund a pilot study to assess a service to supply urgent medicines. However, messages coming from central government are inconsistent. Mowat has said on more than one occasion that a nationally commissioned minor ailment service will be rolled out in England by 2018, but the DH has denied this, saying it is more appropriate that these services are commissioned locally.

Also, the government continues to distance itself from a prediction made early in 2016 that up to 3,000 pharmacies could close as a result of the cuts. “Nobody is talking about thousands of pharmacies closing”, Mowat told MPs in response to an urgent question in the House of Commons on 17 October 2016.

Is subsidy enough?

A pharmacy access scheme, where those pharmacies that have been identified as being either in an area of deprivation or where community pharmacy provision is sparse, will qualify for a monthly subsidy from December 2016 to March 2018. Again, this provision should be welcomed but the jury is still out as to whether the payments — available to less than 12% of all pharmacies in England — will be enough to protect vulnerable pharmacies from closure.

The DH’s impact assessment document, released alongside the funding cuts document, says there is no reliable way of estimating the number of pharmacies that may close as a result of the cuts. If it is not possible to estimate the number of closures, then it is impossible to measure the potential impact on patient care, particularly for vulnerable patients within the community. The stakes are too high for this wait-and-see approach.

The DH contends that, were a pharmacy to close, it is likely that prescriptions that were dispensed by that pharmacy would be redistributed to nearby pharmacies, and this will improve the viability of remaining pharmacies. However, if a pharmacy that offers several clinical services but has a low dispensing volume closes, patients may lose access to a vital service. If pharmacies respond to the cuts by reducing their opening hours and making staff redundant, it will not only reduce the accessibility of community pharmacy services, but clinical quality, too. And services that contractors are not obliged to offer will be the first to go — such as home delivery of medicines and the supply of medicines in compliance aids. It is clear that the impact on patients has not been considered.

Lack of foresight

The government continues to command hardworking healthcare professionals across all sectors to “do more for less”. But it is yet again failing to convince those same healthcare professionals that its plans are carefully thought through or to demonstrate that it has a firm grasp of the consequences for patients and the public — a cavalier approach with every prospect of deeper cuts to come.

While pharmacy organisations try to make sense of the details released, the sector has been given lots of answers for questions that perhaps the government is not in a position to answer. But the sector must do all it can to engage with the process, prove pharmacies’ worth to the NHS and protect vital service provision and patient care.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201872

Readers' comments (1)

  • Graham Phillips

    Where is the patient in all of this? Whatever happened to "no decision about me without me"... 2.2million voters signed a petition against the #pharmacycuts and the Govt ploughed on regardless? How does that work?

    What are the implications for patient safety (and pharmacists' mental health) when the NHS is intentionally depriving pharmacies of resources with the express intention of closing thousands of pharmacies by means of indiscriminate financial attrition? By definition the resources are being deliberately reduced to the point where pharmacies cannot cope and have to close. With ever-growing increases in Rx volume this cavalier approach to patient safety seems to have gone unacknowledged

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Nutraceuticals

    Nutraceuticals

    This authoritative text assesses the medical and scientific evidence for the use of nutraceuticals. Includes monographs on 25 nutraceuticals such as soy and tea.

    £37.00Buy now
  • Medicines Use Reviews

    Medicines Use Reviews

    Conduct successful Medicines Use Reviews (MURs) with this comprehensive book. Contains evidence-based information, tips and guidance.

    £26.00Buy now
  • Traditional Medicine

    Traditional Medicine

    Covers the major traditional medicine systems. Gives information on philosophy, practice, safety, evidence and examples.

    £42.00Buy now
  • Sport and Exercise Medicine for Pharmacists

    Sport and Exercise Medicine for Pharmacists

    All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.

    £26.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Closed pharmacy

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.